PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
2228020-2	1990	The present study investigated whether desferrioxamine operates late in the activation process or, as recently suggested, at an early stage, by inhibiting the appearance of the interleukin-2 (IL-2) receptor.	Deferoxamine	39-54	interleukin 2 receptor subunit beta	Homo sapiens	192-206	
2228020-9	1990	In support of a dual effect of the drug is the finding that at 50 mumol/l, desferrioxamine-enhanced expression of the transferrin receptor occurred, an adaptive response made to intracellular iron depletion, while IL-2 receptor expression was inhibited.	Deferoxamine	75-90	interleukin 2 receptor subunit beta	Homo sapiens	214-227